237 related articles for article (PubMed ID: 33310152)
1. Metformin in acute respiratory distress syndrome: An opinion.
Uddin MA; Akhter MS; Kubra KT; Siejka A; Barabutis N
Exp Gerontol; 2021 Mar; 145():111197. PubMed ID: 33310152
[TBL] [Abstract][Full Text] [Related]
2. Oestrogen-mediated upregulation of the Mas receptor contributes to sex differences in acute lung injury and lung vascular barrier regulation.
Erfinanda L; Ravindran K; Kohse F; Gallo K; Preissner R; Walther T; Kuebler WM
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32764118
[TBL] [Abstract][Full Text] [Related]
3. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability.
Kovacs-Kasa A; Zaied AA; Leanhart S; Koseoglu M; Sridhar S; Lucas R; Fulton DJ; Vazquez JA; Annex BH
Microbiol Spectr; 2022 Feb; 10(1):e0167121. PubMed ID: 35171047
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
5. Brefeldin A and kifunensine modulate LPS-induced lung endothelial hyperpermeability in human and bovine cells.
Kubra KT; Barabutis N
Am J Physiol Cell Physiol; 2021 Aug; 321(2):C214-C220. PubMed ID: 34161151
[TBL] [Abstract][Full Text] [Related]
6. Endothelial Damage in Acute Respiratory Distress Syndrome.
Vassiliou AG; Kotanidou A; Dimopoulou I; Orfanos SE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233715
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
Harrell CR; Jovicic BP; Djonov V; Volarevic V
Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
[TBL] [Abstract][Full Text] [Related]
8. Extensive blood transcriptome analysis reveals cellular signaling networks activated by circulating glycocalyx components reflecting vascular injury in COVID-19.
Borrmann M; Brandes F; Kirchner B; Klein M; Billaud JN; Reithmair M; Rehm M; Schelling G; Pfaffl MW; Meidert AS
Front Immunol; 2023; 14():1129766. PubMed ID: 36776845
[TBL] [Abstract][Full Text] [Related]
9. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
[TBL] [Abstract][Full Text] [Related]
11. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
Soto M; diZerega G; Rodgers KE
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
[TBL] [Abstract][Full Text] [Related]
12. Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment.
Dubrovskyi O; Hasten E; Dudek SM; Flavin MT; Chan LL
SLAS Discov; 2021 Oct; 26(9):1079-1090. PubMed ID: 34269109
[TBL] [Abstract][Full Text] [Related]
13. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
14. Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report.
Teulier M; Elabbadi A; Gerotziafas G; Lionnet F; Voiriot G; Fartoukh M
BMC Pulm Med; 2021 Jan; 21(1):46. PubMed ID: 33514354
[TBL] [Abstract][Full Text] [Related]
15. Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19.
Yamaoka-Tojo M
Biomed J; 2020 Oct; 43(5):399-413. PubMed ID: 33032965
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
[TBL] [Abstract][Full Text] [Related]
17. Prior metformin therapy and 30-day mortality in patients with acute respiratory distress syndrome: a nationwide cohort study.
Oh TK; Song IA
Ann Palliat Med; 2020 May; 9(3):903-911. PubMed ID: 32389018
[TBL] [Abstract][Full Text] [Related]
18. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the Host Response as a Therapeutic Strategy in Severe Lung Infections.
Latreille E; Lee WL
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515150
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption.
Akhter MS; Kubra KT; Barabutis N
Endocrine; 2023 Mar; 79(3):587-592. PubMed ID: 36261700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
